Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Oral Microbiol Immunol ; 24(2): 124-32, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19239639

ABSTRACT

INTRODUCTION: Polymorphonuclear neutrophil (PMN) dysfunctions have been associated with severe forms of periodontitis. This study evaluated the correlation between PMN phagocytosis and oxidative burst with the subgingival microbiota of patients with generalized aggressive periodontitis (GAgP). METHODS: Heparinized peripheral blood samples were obtained from 18 GAgP patients and 11 periodontally healthy (PH) subjects, and PMNs were isolated on a Ficoll-Hypaque gradient. For phagocytosis analysis, PMNs were incubated with fluorescein-labeled Staphylococcus aureus. The oxidative burst was evaluated by incubation of PMNs with dihydroethidium and activation by S. aureus. The assays were examined using flow cytometry. Subgingival biofilm samples were obtained from periodontal sites with and without periodontitis and 24 species were detected by checkerboard. RESULTS: A significantly lower phagocytosis rate was observed for patients with GAgP compared with PH subjects over time (P < 0.05). No differences between groups were found for superoxide production. GAgP patients presented significantly higher prevalence and levels of Porphyromonas gingivalis, Tannerella forsythia, and Aggregatibacter actinomycetemcomitans serotype b than controls (P < 0.05). Significant negative correlations between T. forsythia and P. gingivalis and PMN functions were observed. CONCLUSIONS: GAgP subjects presented diminished phagocytic activity of peripheral PMNs and high prevalence and levels of classical periodontal pathogens.


Subject(s)
Aggressive Periodontitis/immunology , Aggressive Periodontitis/microbiology , Neutrophils/immunology , Periodontal Pocket/microbiology , Adult , Aggregatibacter actinomycetemcomitans/immunology , Aggregatibacter actinomycetemcomitans/isolation & purification , Bacteroides/immunology , Bacteroides/isolation & purification , Case-Control Studies , Female , Flow Cytometry , Humans , Male , Phagocytosis , Porphyromonas gingivalis/immunology , Porphyromonas gingivalis/isolation & purification , Respiratory Burst , Streptococcus/immunology , Streptococcus/isolation & purification
2.
Br J Pharmacol ; 153(3): 528-35, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18037915

ABSTRACT

BACKGROUND: Prostaglandin E(2) (PGE(2)) suppresses, while indomethacin and aspirin enhance, eosinophil production in murine liquid bone-marrow cultures. Because cysteinyl leukotrienes (cys-LTs) enhance human eosinophil colony formation, we investigated whether the effects of indomethacin and aspirin on murine bone-marrow were due to blockade of PGE(2) production alone, or involved further promotion of cys-LTs production/signalling. EXPERIMENTAL APPROACH: BALB/c liquid bone-marrow cultures were established with IL-5, alone or associated with indomethacin, aspirin, or cys-LTs. The effects of preventing cys-LT production or signalling were assessed. KEY RESULTS: Indomethacin and aspirin counteracted the suppression of eosinophil production by exogenous PGE(2). LTD(4), LTC(4) and LTE(4) enhanced IL-5-dependent eosinophil production and further counteracted the effect of exogenous PGE(2). The 5-lipoxygenase activating protein (FLAP) inhibitor, MK886, a leukotriene synthesis inhibitor, zileuton, the CysLT(1) receptor antagonists, MK571 and montelukast, or inactivation of the LTC(4) synthase gene, abolished effects of indomethacin and aspirin. MK886 and zileuton were ineffective but MK571 and montelukast were effective, against LTD(4). Indomethacin, aspirin and LTD(4) failed to enhance eosinophil production in bone-marrow from CysLT1 receptor-deficient mice. Indomethacin, aspirin and LTD(4) no longer counteracted the effects of exogenous PGE(2) in the presence of MK571 and montelukast. MK886, MK571 and montelukast had no effect by themselves, or in association with PGE(2). CONCLUSIONS AND IMPLICATIONS: Dependence on the FLAP/5-lipoxygenase/LTC(4) synthase pathway and receptor signalling shows that cyclo-oxygenase inhibitors act here through endogenous cys-LTs. While PGE(2) does not act by suppressing cys-LT production, cys-LTs override PGE(2) signalling. Eosinophil production is therefore coordinately regulated by both pathways.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Aspirin/pharmacology , Cysteine/metabolism , Indomethacin/pharmacology , Leukotrienes/metabolism , 5-Lipoxygenase-Activating Proteins , Animals , Bone Marrow Cells/drug effects , Bone Marrow Cells/metabolism , Carrier Proteins/metabolism , Cells, Cultured , Cyclooxygenase Inhibitors/pharmacology , Cysteine/drug effects , Dinoprostone/metabolism , Eosinophils/drug effects , Eosinophils/metabolism , Female , Glutathione Transferase/metabolism , Male , Membrane Proteins/metabolism , Mice , Mice, Inbred BALB C , Signal Transduction
3.
Am J Respir Cell Mol Biol ; 17(4): 404-13, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9376115

ABSTRACT

To define the effects of immunization and exposure to allergen on the eosinophil lineage, we studied blood and bone-marrow eosinophil numbers, serum interleukin (IL)-5 levels, and eosinophil progenitor and precursor responses to IL-3 and IL-5 in ovalbumin-immunized BALB/c mice after intranasal challenge. Increased blood eosinophilia was found in immune relative to nonimmune mice, but the differences between challenged and unchallenged immune animals were not significant. In contrast, significantly increased circulating levels of IL-5 and numbers of bone-marrow eosinophils were found in sensitized animals exposed to allergen, relative to unchallenged, sensitized controls. An allergen-induced increase in IL-3-sensitive progenitors yielding eosinophil-bearing colonies was also found at 2 h after challenge. Furthermore, an eosinophil differentiation assay showed a marked increase in the magnitude of the responses to IL-5 and IL-3 over a 7-day period in bone-marrow cells of sensitized animals, which was detectable at 24 h after allergen challenge, but not at 2 h and not in unchallenged controls. Modulation of the responses of bone-marrow cells to IL-5 is induced by a circulating factor present in challenged immune animals, as shown by in vivo plasma transfer, but is at best only partly blocked by in vivo treatment with the anti-IL-5 antibody TRFK-5. These data indicate that allergen challenge in the airways leads to rapid long-term modifications in bone-marrow eosinophil progenitors and precursors, and that increased responses to eosinopoietins in bone marrow depend on the release, between 2 h and 24 h after challenge, of a circulating factor distinct from IL-5.


Subject(s)
Allergens/immunology , Bone Marrow Cells/immunology , Eosinophils/immunology , Interleukin-5/immunology , Ovalbumin/immunology , Administration, Intranasal , Allergens/administration & dosage , Animals , Blood Cell Count , Bone Marrow Cells/pathology , Eosinophils/pathology , Female , Hematopoiesis/drug effects , Hematopoietic Stem Cells/drug effects , Interleukin-3/pharmacology , Interleukin-5/blood , Interleukin-5/pharmacology , Male , Mice , Mice, Inbred BALB C , Ovalbumin/administration & dosage
4.
Clin Exp Allergy ; 27(2): 208-17, 1997 Feb.
Article in English | MEDLINE | ID: mdl-9061222

ABSTRACT

BACKGROUND: Alveolar macrophages (AM) may participate in brochopulmonary hyper-reactivity by secreting cytokines that recruit mature eosinophils, or induce eosinophil production from recruited circulating progenitors. OBJECTIVE: To define whether AM products can contribute to lung eosinophil production in immunized guinea pigs (GP), by analysing the effect of AM culture supernatants (AM-SN) on in vitro eosinophilopoiesis. METHODS: Liquid and semi-solid bone marrow (BM) cultures were seeded with SN from 95% pure AM exposed to LPS. RESULTS: AM-SN increased very significantly the long-term viability, cell proliferation and eosinophil production in liquid culture and supported formation of eosinophil-bearing mixed colonies, by acting on progenitors depleted of mature eosinophils. The effect on eosinophil production was not duplicated by natural or recombinant sources of GM-CSF (which nevertheless supported GM colony formation by GP BM), not by rhIL-8 (which was active on GP cells) and was not due to residual LPS. FPLC separation of active AM SN yielded a peak of apparent m.w. 43 kDa, active on both liquid and semi-solid cultures. The active moiety was heat- and trypsin-resistant. Neutralizing monoclonal antibodies to hGM-CSF, mGM-CSF, hIL-3 and mIL-3 failed to deplete the activity in AM-SN. Ovalbumin immunization induced its production by AM even without LPS challenge. CONCLUSIONS: The lack of T lymphocytes among factor-producing AM, the properties of the active material, the inability of GM-CSF to reproduce these effects, and the failure of MoAbs to GM-CSF and to IL-3 to neutralize the activity indicate it is not due to the major eosinopoietic factors GM-CSF, IL-3 or IL-5.


Subject(s)
Eosinophils/drug effects , Hematopoietic Stem Cells/drug effects , Hot Temperature , Macrophages, Alveolar/immunology , Macrophages, Alveolar/metabolism , Ovalbumin/immunology , Animals , Bone Marrow Cells , Cell-Free System/chemistry , Cell-Free System/immunology , Cell-Free System/metabolism , Cells, Cultured , Eosinophils/immunology , Female , Guinea Pigs , Hematopoietic Stem Cells/immunology , Injections, Subcutaneous , Interleukin-8/pharmacology , Macrophages, Alveolar/chemistry , Male , Ovalbumin/administration & dosage
5.
Blood ; 75(12): 2427-33, 1990 Jun 15.
Article in English | MEDLINE | ID: mdl-2190641

ABSTRACT

Monoclonal antibodies (MoAbs) to the eosinophil cytotoxicity-enhancing factor (ECEF) were used to detect ECEF in U937 cells before and after phorbol ester (PMA)-induced differentiation into ECEF-secreting macrophages. Membrane-associated ECEF (mECEF), apparently an integral membrane component, is found in U937 cells and in 70% of monocytes and, at lower levels, on blood T lymphocytes. Expression of mECEF in U937 cells is heterogeneous, as is responsiveness to PMA. In PMA-treated cultures, the strongest mECEF expression is on adherent, differentiated macrophages, rather than on activated, nonadherent cells. To study the relationship of mECEF to PMA responsiveness, we positively selected by "panning" a cell line (U937 P+) with significantly higher mECEF expression than that of U937. U937 P+ cells respond to PMA as a differentiation stimulus more effectively than do U937 cells, with a fourfold increase in the number of differentiated macrophages (P less than .001) and a faster rate of differentiation (a fourfold increase at t = 12 hours, P less than .001). U937 P+ cells also show a 7.4-fold increase in response to suboptimal doses of PMA (P less than .001). These findings suggest that mECEF expression correlates with responsiveness to a differentiation stimulus in a histiocytic lymphoma cell line that is widely used as a model of monocyte maturation.


Subject(s)
Antibodies, Monoclonal/immunology , Eosinophils/physiology , Lymphoma, Large B-Cell, Diffuse/pathology , Macrophages/cytology , Monokines/physiology , Biological Factors/physiology , Cell Adhesion , Cell Differentiation/drug effects , Cell Separation , Cytokines , Cytotoxicity, Immunologic , Humans , In Vitro Techniques , Membrane Proteins/physiology , Tetradecanoylphorbol Acetate/pharmacology , Tumor Cells, Cultured
6.
Eur J Immunol ; 20(5): 1143-51, 1990 May.
Article in English | MEDLINE | ID: mdl-2192904

ABSTRACT

The monokine eosinophil cytotoxicity enhancing factor (ECEF) increases antibody-dependent cytotoxicity of eosinophils towards helminth larvae. A monokine biochemically indistinguishable from ECEF increases the release of leukotriene C4 and other arachidonic acid metabolites by eosinophils. We have developed monoclonal antibodies (mAb) to these monokines by immunizing mice with ECEF made by the U-937 histiocytic lymphoma cell line. mAb 81.10.C9 (IgG2b) and 9A6G (IgG1) inhibit the effect of the monokine on release of AA products. Both mAb bind ECEF, which appears after affinity chromatography purification as a major 13-14-kDa and a minor 62-kDa component (13-14 kDa and 52 kDa after reduction) in silver-stained gels. An additional component of 30 kDa is detectable after radioiodination of the immunopurified material. The specificity of both mAb was studied in several ways. In immunoprecipitation, both recognize the 13-14-kDa and the 30-kDa components, while the 62-(52)-kDa protein is not significantly precipitated. Both mAb react in enzyme-linked immunosorbent assay with products secreted by peripheral blood mononuclear cells and monocytes, as well as with those secreted by phorbol 12-myristate 13-acetate and lipopolysaccharide-stimulated U-937 cells and with the immunopurified proteins. These were separated in sodium dodecyl sulfate-polyacrylamide gel electrophoresis, electroeluted and assayed for ECEF activity. Activity was associated with the 13-14-kDa and the 30-kDa fractions, as seen by increased eosinophil antibody-dependent adherence to schistosomula and cytotoxicity. Granulocyte-monocyte-colony-stimulating factor and interleukin 1, but not tumor necrosis factor, could be detected in crude U-937 supernatants. However, active immunopurified ECEF has no activity in assays for granulocyte-monocyte-colony-stimulating factor, interleukin 1 or tumor necrosis factor. Immunocytochemical localization of ECEF employing the mAb shows strong surface staining of viable monocytes and U-937 cells, suggesting that ECEF is associated to the cell surface. These properties distinguish ECEF from other monokines previously reported to activate eosinophils.


Subject(s)
Eosinophils/immunology , Monocytes/immunology , Monokines/isolation & purification , Antibodies, Monoclonal , Antibody Specificity , Arachidonic Acids/metabolism , Biological Factors , Chromatography, Affinity , Colony-Stimulating Factors/analysis , Cytokines , Electrophoresis, Polyacrylamide Gel , Eosinophils/metabolism , Granulocyte-Macrophage Colony-Stimulating Factor , Growth Substances/analysis , Humans , Immunohistochemistry , Immunosorbent Techniques , In Vitro Techniques , Interleukin-1/analysis , Molecular Weight , Monokines/analysis , Tumor Necrosis Factor-alpha/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...